Our Recommendations
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
- Monkeypox: Caring for the skin (2022)
- Laboratory manual for yellow fever (2024)
- Management of a cholera epidemic - Practical guide for doctors, nurses, laboratory technicians, medical auxiliaries, water and sanitation specialists and logisticians (2023)
New Publications
- Guideline on management of pneumonia and diarrhoea in children up to 10 years of age (2024)
- Revised National Guidelines on Mpox (2024)
- Skin NTDs App (2024)
- Multiple first-line therapies as part of the response to antimalarial drug resistance (2024)
- Considerations for wastewater and environmental surveillance for monkeypox virus: interim guidance, 25 November 2024 (2024)
Filter
549
Featured
Recommendations
96
New Publications
129
Language
Document type
No document type
239
Guidelines
140
Studies & Reports
38
Manuals
33
Strategic & Response Plan
27
Fact sheets
19
Online Courses
14
Training Material
13
Resource Platforms
9
Infographics
7
Situation Updates
6
Videos
3
App
1
Countries / Regions
Global
19
Latin America and the Carribbean
15
Africa
9
Ukraine
8
India
8
Middle East and North Africa
6
Russia
6
Congo, Democratic Republic of
5
Western and Central Europe
5
Brazil
5
Mozambique
4
South–East Asia Region
4
South Africa
4
Haiti
3
Germany
3
West and Central Africa
3
East and Southern Africa
3
Eastern Europe
3
Yemen
3
Kenya
2
Nigeria
2
Zimbabwe
2
Bangladesh
2
Zambia
2
Somalia
2
Pakistan
2
Nepal
1
Colombia
1
Sierra Leone
1
Chile
1
Syria
1
Senegal
1
Uzbekistan
1
Afghanistan
1
Malawi
1
Guinea
1
USA
1
Asia
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Argentina
1
Sri Lanka
1
Angola
1
Bhutan
1
Liberia
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Toolboxes
Rapid Response
96
TB
83
HIV
54
Cholera
21
Refugee
19
COVID-19
14
Caregiver
13
Ebola
6
Conflict
6
Polio
6
Natural Hazards
5
AMR
3
Mental Health
2
Planetary Health
2
Pharmacy
1
NTDs
1
Health Financing Toolbox
1
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Estimated number of pregnant women, number with access to at least four antenatal care visits, and those delivering in hospital settings in the Americas, 2019...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health coverage.
The road map will reinforce and combine with wider initiatives, such as those aimed at s...
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les...
La meningitis es una enfermedad mortal y debilitante; golpea rápidamente, conlleva graves consecuencias sanitarias, económicas y sociales, y afecta a personas de todas las edades y en todos los países del mundo. La meningitis bacteriana puede provocar epidemias, ocasionar la muerte en 24 horas y ...
Defeating meningitis by 2030: a global road map
Defeating meningitis by 2030: a roadmap
Mycetoma is a chronic, progressively destructive infectious disease of the subcutaneous tissues, affecting skin, muscle and bone. Mycetoma occurs in tropical and subtropical environments characterized by short rainy seasons and prolonged dry seasons that favour the growth of thorny bushes. Global bu...
Learn about the first Malaria vaccine. Who should receive this vaccine? What are the challenges of rolling out a Malaria vaccine in the midst of a pandemic? Dr Pedro Alonso explains in Science in 5 this week.
Testing men for HIV during their partner’s pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HIV-negative ...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
